Javascript must be enabled to continue!
A STUDY ON CLINICOPATHOLOGICAL PROFILE OF ORAL SUBMUCOUS FIBROSIS
View through CrossRef
Background: Oral submucous brosis is a leading cause of oral cancer. So it is necessary to study its clinicopathological prole for the early diagnosis and prompt treatment. To assess the clinical prole and to eval Objectives: uate the histological prole of oral submucous brosis. Materials and Methods: A cross-sectional observational study conducted in the Department of Otorhinolaryngology, Regional Institute of Medical Sciences, Imphal, Manipur, India for a period of 2 years from September 2018 to August 2020. 78 oral submucous brosis patients were enrolled for the study. Clinical features, different habits and histopathological features were studied. Majority of the patients were in the Results: age group 21-30 years with male to female ratio of 1:1.36. Gutkha/talab was the most common habit among the study population. The mean duration of habits was 5.51 years with a minimum duration of 2 years and maximum duration of 15years. Majority of the patients (65.4%) had duration of habits of 1-5 years. Most of the patients (65.4%) clinically presented with difculty in opening of mouth. Fibrosis was most commonly seen in buccal mucosa and palate. Most of the patients were in clinical stage II (57.7%) and in histopathological grade II (60.3%). There was no statistically signicant correlation found between clinical staging and histopathological grading (P value – 0.627) Gutkha/talab is Conclusion: more responsible for the development of oral submucous brosis. Early diagnosis and treatment is important to prevent the progression to oral cancer.
Title: A STUDY ON CLINICOPATHOLOGICAL PROFILE OF ORAL SUBMUCOUS FIBROSIS
Description:
Background: Oral submucous brosis is a leading cause of oral cancer.
So it is necessary to study its clinicopathological prole for the early diagnosis and prompt treatment.
To assess the clinical prole and to eval Objectives: uate the histological prole of oral submucous brosis.
Materials and Methods: A cross-sectional observational study conducted in the Department of Otorhinolaryngology, Regional Institute of Medical Sciences, Imphal, Manipur, India for a period of 2 years from September 2018 to August 2020.
78 oral submucous brosis patients were enrolled for the study.
Clinical features, different habits and histopathological features were studied.
Majority of the patients were in the Results: age group 21-30 years with male to female ratio of 1:1.
36.
Gutkha/talab was the most common habit among the study population.
The mean duration of habits was 5.
51 years with a minimum duration of 2 years and maximum duration of 15years.
Majority of the patients (65.
4%) had duration of habits of 1-5 years.
Most of the patients (65.
4%) clinically presented with difculty in opening of mouth.
Fibrosis was most commonly seen in buccal mucosa and palate.
Most of the patients were in clinical stage II (57.
7%) and in histopathological grade II (60.
3%).
There was no statistically signicant correlation found between clinical staging and histopathological grading (P value – 0.
627) Gutkha/talab is Conclusion: more responsible for the development of oral submucous brosis.
Early diagnosis and treatment is important to prevent the progression to oral cancer.
Related Results
Expression and methylation of Dickkopf‐1 in the pathogenesis and malignant transformation of oral submucous fibrosis
Expression and methylation of Dickkopf‐1 in the pathogenesis and malignant transformation of oral submucous fibrosis
AbstractBackgroundDickkopf‐1 is an inhibitor of the Wnt/β‐catenin pathway, but the role of Dickkopf‐1 in oral submucous fibrosis remains unclear. We evaluated the protein expressio...
Oral Submucous Fibrosis Association with Sociodemographic and Personal Habits of Dental Patients Visiting Tertiary Care Hospital in Hyderabad
Oral Submucous Fibrosis Association with Sociodemographic and Personal Habits of Dental Patients Visiting Tertiary Care Hospital in Hyderabad
Introduction: Sociodemographic and personal habits are variable among patients with oral submucous fibrosis and are important to know to see the pattern of these factors in oral su...
Role of Oxidative Stress Markers and Antioxidants in Diagnosis of Oral Submucous Fibrosis
Role of Oxidative Stress Markers and Antioxidants in Diagnosis of Oral Submucous Fibrosis
Background: Oral submucous fibrosis is a chronic disease affecting oral cavity. The pathological changes in this disease cause an increase in markers of oxidative stress and decrea...
Distribution of Oral Submucous Fibrosis Cases and Malignant Transformation Rate among Bhutanese Patients Treated at Jigme Dorji Wangchuck National Referral Hospital, Bhutan
Distribution of Oral Submucous Fibrosis Cases and Malignant Transformation Rate among Bhutanese Patients Treated at Jigme Dorji Wangchuck National Referral Hospital, Bhutan
BACKGROUND: Oral Submucous Fibrosis (OSMF) is a chronic, insidious, scarring disease of the mouth often involving the palate, oro-pharynx, pharynx, esophagus, tongue and the buccal...
A revised classification of the cleft lip and palate
A revised classification of the cleft lip and palate
Background
Submucous cleft palate is characterized by muscular diastasis of the velum in the presence of intact mucosa with variable combinations of bifid uvula...
Impact of Oral Submucous Fibrosis on Quality of Life
Impact of Oral Submucous Fibrosis on Quality of Life
Background: Oral submucous fibrosis (OSMF) is a chronic, insidious, potentially malignant condition primarily affecting populations with areca nut chewing habits. It significantly ...
The NAFLD fibrosis score : a prognostic predictor for mortality and liver complications among NAFLD patients
The NAFLD fibrosis score : a prognostic predictor for mortality and liver complications among NAFLD patients
Background: The prognostic indicators for long-term outcomes of non alcoholic fatty liver disease (NAFLD) patients have not been well studied. We aimed to validate the NAFLD Fibros...
Bone Marrow Fibrosis in Patients with Inherited Bone Marrow Failure Syndromes.
Bone Marrow Fibrosis in Patients with Inherited Bone Marrow Failure Syndromes.
Abstract
Abstract 3192
Poster Board III-129
Introduction
Bone marrow fibrosis has been reported in...

